LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

86 filings reported holding LENZ - LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share as of Q3 2024.
LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,735,645 shares of 28,248,974 outstanding shares and own 66% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4,178,823 shares), Alpha Wave Global, LP (3,612,211 shares), Samsara BioCapital, LLC (1,208,473 shares), VANGUARD GROUP INC (1,118,817 shares), 72 Investment Holdings, LLC (1,017,751 shares), SECTORAL ASSET MANAGEMENT INC (977,245 shares), BlackRock, Inc. (930,021 shares), Point72 Asset Management, L.P. (864,942 shares), RTW INVESTMENTS, LP (863,389 shares), and TANG CAPITAL MANAGEMENT LLC (766,940 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.